CELL CYCLE 润色咨询

CELL CYCLE

出版年份：2002 年文章数：4437 投稿命中率： 开通期刊会员，数据随心看

出版周期：Semimonthly 自引率：3.1% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=915935, encodeId=e639915935e0, content=文章已经接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210513/47b3d9cb927445389014f5811b21dfd1/d6c5299aff574499b0b1989cb9ed6c93.jpg, createdBy=06772417024, createdName=1238a8f4m21(暂无昵称), createdTime=Tue Jan 12 15:52:35 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229537, encodeId=9cf6122953e16, content=偏重的研究方向：肿瘤;非编码RNA;细胞增殖<br>经验分享：6.17号投稿，第二天让补一个文件，大概18号变成with editor，24号开始就是Under Review，算是送外审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b675286815, createdName=148551b4m72(暂无昵称), createdTime=Wed Jun 29 19:42:18 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091466, encodeId=6a4d2091466ab, content=请问通讯作者不是自己投稿后，说要通过通讯作者的邮箱确认上传，那投稿进程也只能通讯作者看到吗，这样好麻烦啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7b08246697, createdName=ms1000000486045935, createdTime=Sun Oct 02 13:51:26 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216306, encodeId=5cfe1216306ca, content=ARRIVE Guidelines 在哪里下载呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIDnGE4d0tX0MqJHQj7shA3cuwKBNoG8wgelODu2fMn2rsk2aMT40SFmy9ZHQib09w7sJhDmZODwRw/132, createdBy=e43c2283843, createdName=maoweipu, createdTime=Mon May 02 13:56:31 CST 2022, time=2022-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248951, encodeId=f50c124895189, content=偏重的研究方向：细胞周期<br>经验分享：这杂志三个月了一直under review吗 有没有大牛指导下咋回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=803b6564452, createdName=ms7000001615775824, createdTime=Wed Sep 14 21:16:44 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089205, encodeId=145c208920522, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：研究类型;论文投稿;动物研究<br>经验分享：<a href='/topic/show?id=0fbb104230d8' target=_blank style='color:#2F92EE;'>#论文投稿#</a><a href='/topic/show?id=b69d5605275' target=_blank style='color:#2F92EE;'>#报告规范#</a>的要求，RCT则要求是否符合<a href='/topic/show?id=a988506424' target=_blank style='color:#2F92EE;'>#CONSORT#</a>规范（https://www.medsci.cn/guideline/show_article.do?id=71eb11c0021e2098），<a href='/topic/show?id=4c65331e364' target=_blank style='color:#2F92EE;'>#动物研究#</a>需要符合<a href='/topic/show?id=0d62104e834a' target=_blank style='color:#2F92EE;'>#ARRIVE#</a>规范，见：https://www.medsci.cn/guideline/show_article.do?id=fc3d31c002219a71 观察性研究需要符合<a href='/topic/show?id=e6b816841ea' target=_blank style='color:#2F92EE;'>#STROBE#</a>规范（https://www.medsci.cn/guideline/search?keyword=STROBE&page=1），这些在梅斯的“指南频道”中都可以检索得到的。<br>如果是动物研究，下载ARRIVE对应的文章后，文章里面有一个checklist，按checklist填写每个部分对应文章的哪一页即可，这样10分钟就能填好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104230, encryptionId=0fbb104230d8, topicName=论文投稿), TopicDto(id=56052, encryptionId=b69d5605275, topicName=报告规范), TopicDto(id=5064, encryptionId=a988506424, topicName=CONSORT), TopicDto(id=33173, encryptionId=4c65331e364, topicName=动物研究), TopicDto(id=104783, encryptionId=0d62104e834a, topicName=ARRIVE), TopicDto(id=16841, encryptionId=e6b816841ea, topicName=STROBE)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Tue Sep 20 03:46:02 CST 2022, time=2022-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212801, encodeId=8504121280160, content=偏重的研究方向：细胞凋亡;程序性坏死;细胞增殖<br>经验分享：投的纯生信， 3.22第一次投稿， 4.7日返修，给了四个月，三个审稿人， 审稿人问题不难回答，也没有让补实验， 改完以后4.13日返修回去， 4.18under review 现在等待结果中。祝好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e995108255, createdName=话雨临风, createdTime=Wed Apr 20 10:58:07 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965179, encodeId=adb69651e951, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向： 细胞周期 ; 细胞凋亡 ; 细胞增殖 <br>经验分享：优点不要钱 缺点周期很长 2020-9-4投稿 2020-9-30第一次修回 2020-11-24第二次修回 2020-12-29接收 2021-5-8 onli n e 着急毕业的审投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210513/47b3d9cb927445389014f5811b21dfd1/d6c5299aff574499b0b1989cb9ed6c93.jpg, createdBy=06772417024, createdName=1238a8f4m21(暂无昵称), createdTime=Thu May 13 12:10:37 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803989, encodeId=95c38039898a, content=请问怎么撤稿啊，急着换一个杂志，这个等太久了。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef1f5402218, createdName=ms1000000350261178, createdTime=Wed Jul 22 20:47:04 CST 2020, time=2020-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209983, encodeId=a1041209983eb, content=现在是不是吉大预警期刊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e995108255, createdName=话雨临风, createdTime=Sun Apr 10 09:30:04 CST 2022, time=2022-04-10, status=1, ipAttribution=)]
    2021-01-12 1238a8f4m21(暂无昵称)

    文章已经接受

    2

    展开2条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=915935, encodeId=e639915935e0, content=文章已经接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210513/47b3d9cb927445389014f5811b21dfd1/d6c5299aff574499b0b1989cb9ed6c93.jpg, createdBy=06772417024, createdName=1238a8f4m21(暂无昵称), createdTime=Tue Jan 12 15:52:35 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229537, encodeId=9cf6122953e16, content=偏重的研究方向：肿瘤;非编码RNA;细胞增殖<br>经验分享：6.17号投稿，第二天让补一个文件，大概18号变成with editor，24号开始就是Under Review，算是送外审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b675286815, createdName=148551b4m72(暂无昵称), createdTime=Wed Jun 29 19:42:18 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091466, encodeId=6a4d2091466ab, content=请问通讯作者不是自己投稿后，说要通过通讯作者的邮箱确认上传，那投稿进程也只能通讯作者看到吗，这样好麻烦啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7b08246697, createdName=ms1000000486045935, createdTime=Sun Oct 02 13:51:26 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216306, encodeId=5cfe1216306ca, content=ARRIVE Guidelines 在哪里下载呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIDnGE4d0tX0MqJHQj7shA3cuwKBNoG8wgelODu2fMn2rsk2aMT40SFmy9ZHQib09w7sJhDmZODwRw/132, createdBy=e43c2283843, createdName=maoweipu, createdTime=Mon May 02 13:56:31 CST 2022, time=2022-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248951, encodeId=f50c124895189, content=偏重的研究方向：细胞周期<br>经验分享：这杂志三个月了一直under review吗 有没有大牛指导下咋回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=803b6564452, createdName=ms7000001615775824, createdTime=Wed Sep 14 21:16:44 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089205, encodeId=145c208920522, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：研究类型;论文投稿;动物研究<br>经验分享：<a href='/topic/show?id=0fbb104230d8' target=_blank style='color:#2F92EE;'>#论文投稿#</a><a href='/topic/show?id=b69d5605275' target=_blank style='color:#2F92EE;'>#报告规范#</a>的要求，RCT则要求是否符合<a href='/topic/show?id=a988506424' target=_blank style='color:#2F92EE;'>#CONSORT#</a>规范（https://www.medsci.cn/guideline/show_article.do?id=71eb11c0021e2098），<a href='/topic/show?id=4c65331e364' target=_blank style='color:#2F92EE;'>#动物研究#</a>需要符合<a href='/topic/show?id=0d62104e834a' target=_blank style='color:#2F92EE;'>#ARRIVE#</a>规范，见：https://www.medsci.cn/guideline/show_article.do?id=fc3d31c002219a71 观察性研究需要符合<a href='/topic/show?id=e6b816841ea' target=_blank style='color:#2F92EE;'>#STROBE#</a>规范（https://www.medsci.cn/guideline/search?keyword=STROBE&page=1），这些在梅斯的“指南频道”中都可以检索得到的。<br>如果是动物研究，下载ARRIVE对应的文章后，文章里面有一个checklist，按checklist填写每个部分对应文章的哪一页即可，这样10分钟就能填好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104230, encryptionId=0fbb104230d8, topicName=论文投稿), TopicDto(id=56052, encryptionId=b69d5605275, topicName=报告规范), TopicDto(id=5064, encryptionId=a988506424, topicName=CONSORT), TopicDto(id=33173, encryptionId=4c65331e364, topicName=动物研究), TopicDto(id=104783, encryptionId=0d62104e834a, topicName=ARRIVE), TopicDto(id=16841, encryptionId=e6b816841ea, topicName=STROBE)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Tue Sep 20 03:46:02 CST 2022, time=2022-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212801, encodeId=8504121280160, content=偏重的研究方向：细胞凋亡;程序性坏死;细胞增殖<br>经验分享：投的纯生信， 3.22第一次投稿， 4.7日返修，给了四个月，三个审稿人， 审稿人问题不难回答，也没有让补实验， 改完以后4.13日返修回去， 4.18under review 现在等待结果中。祝好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e995108255, createdName=话雨临风, createdTime=Wed Apr 20 10:58:07 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965179, encodeId=adb69651e951, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向： 细胞周期 ; 细胞凋亡 ; 细胞增殖 <br>经验分享：优点不要钱 缺点周期很长 2020-9-4投稿 2020-9-30第一次修回 2020-11-24第二次修回 2020-12-29接收 2021-5-8 onli n e 着急毕业的审投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210513/47b3d9cb927445389014f5811b21dfd1/d6c5299aff574499b0b1989cb9ed6c93.jpg, createdBy=06772417024, createdName=1238a8f4m21(暂无昵称), createdTime=Thu May 13 12:10:37 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803989, encodeId=95c38039898a, content=请问怎么撤稿啊，急着换一个杂志，这个等太久了。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef1f5402218, createdName=ms1000000350261178, createdTime=Wed Jul 22 20:47:04 CST 2020, time=2020-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209983, encodeId=a1041209983eb, content=现在是不是吉大预警期刊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e995108255, createdName=话雨临风, createdTime=Sun Apr 10 09:30:04 CST 2022, time=2022-04-10, status=1, ipAttribution=)]
    2022-06-29 148551b4m72(暂无昵称)

    偏重的研究方向：肿瘤;非编码RNA;细胞增殖
    经验分享：6.17号投稿，第二天让补一个文件，大概18号变成with editor，24号开始就是Under Review，算是送外审了吗

    4

    展开4条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=915935, encodeId=e639915935e0, content=文章已经接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210513/47b3d9cb927445389014f5811b21dfd1/d6c5299aff574499b0b1989cb9ed6c93.jpg, createdBy=06772417024, createdName=1238a8f4m21(暂无昵称), createdTime=Tue Jan 12 15:52:35 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229537, encodeId=9cf6122953e16, content=偏重的研究方向：肿瘤;非编码RNA;细胞增殖<br>经验分享：6.17号投稿，第二天让补一个文件，大概18号变成with editor，24号开始就是Under Review，算是送外审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b675286815, createdName=148551b4m72(暂无昵称), createdTime=Wed Jun 29 19:42:18 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091466, encodeId=6a4d2091466ab, content=请问通讯作者不是自己投稿后，说要通过通讯作者的邮箱确认上传，那投稿进程也只能通讯作者看到吗，这样好麻烦啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7b08246697, createdName=ms1000000486045935, createdTime=Sun Oct 02 13:51:26 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216306, encodeId=5cfe1216306ca, content=ARRIVE Guidelines 在哪里下载呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIDnGE4d0tX0MqJHQj7shA3cuwKBNoG8wgelODu2fMn2rsk2aMT40SFmy9ZHQib09w7sJhDmZODwRw/132, createdBy=e43c2283843, createdName=maoweipu, createdTime=Mon May 02 13:56:31 CST 2022, time=2022-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248951, encodeId=f50c124895189, content=偏重的研究方向：细胞周期<br>经验分享：这杂志三个月了一直under review吗 有没有大牛指导下咋回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=803b6564452, createdName=ms7000001615775824, createdTime=Wed Sep 14 21:16:44 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089205, encodeId=145c208920522, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：研究类型;论文投稿;动物研究<br>经验分享：<a href='/topic/show?id=0fbb104230d8' target=_blank style='color:#2F92EE;'>#论文投稿#</a><a href='/topic/show?id=b69d5605275' target=_blank style='color:#2F92EE;'>#报告规范#</a>的要求，RCT则要求是否符合<a href='/topic/show?id=a988506424' target=_blank style='color:#2F92EE;'>#CONSORT#</a>规范（https://www.medsci.cn/guideline/show_article.do?id=71eb11c0021e2098），<a href='/topic/show?id=4c65331e364' target=_blank style='color:#2F92EE;'>#动物研究#</a>需要符合<a href='/topic/show?id=0d62104e834a' target=_blank style='color:#2F92EE;'>#ARRIVE#</a>规范，见：https://www.medsci.cn/guideline/show_article.do?id=fc3d31c002219a71 观察性研究需要符合<a href='/topic/show?id=e6b816841ea' target=_blank style='color:#2F92EE;'>#STROBE#</a>规范（https://www.medsci.cn/guideline/search?keyword=STROBE&page=1），这些在梅斯的“指南频道”中都可以检索得到的。<br>如果是动物研究，下载ARRIVE对应的文章后，文章里面有一个checklist，按checklist填写每个部分对应文章的哪一页即可，这样10分钟就能填好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104230, encryptionId=0fbb104230d8, topicName=论文投稿), TopicDto(id=56052, encryptionId=b69d5605275, topicName=报告规范), TopicDto(id=5064, encryptionId=a988506424, topicName=CONSORT), TopicDto(id=33173, encryptionId=4c65331e364, topicName=动物研究), TopicDto(id=104783, encryptionId=0d62104e834a, topicName=ARRIVE), TopicDto(id=16841, encryptionId=e6b816841ea, topicName=STROBE)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Tue Sep 20 03:46:02 CST 2022, time=2022-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212801, encodeId=8504121280160, content=偏重的研究方向：细胞凋亡;程序性坏死;细胞增殖<br>经验分享：投的纯生信， 3.22第一次投稿， 4.7日返修，给了四个月，三个审稿人， 审稿人问题不难回答，也没有让补实验， 改完以后4.13日返修回去， 4.18under review 现在等待结果中。祝好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e995108255, createdName=话雨临风, createdTime=Wed Apr 20 10:58:07 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965179, encodeId=adb69651e951, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向： 细胞周期 ; 细胞凋亡 ; 细胞增殖 <br>经验分享：优点不要钱 缺点周期很长 2020-9-4投稿 2020-9-30第一次修回 2020-11-24第二次修回 2020-12-29接收 2021-5-8 onli n e 着急毕业的审投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210513/47b3d9cb927445389014f5811b21dfd1/d6c5299aff574499b0b1989cb9ed6c93.jpg, createdBy=06772417024, createdName=1238a8f4m21(暂无昵称), createdTime=Thu May 13 12:10:37 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803989, encodeId=95c38039898a, content=请问怎么撤稿啊，急着换一个杂志，这个等太久了。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef1f5402218, createdName=ms1000000350261178, createdTime=Wed Jul 22 20:47:04 CST 2020, time=2020-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209983, encodeId=a1041209983eb, content=现在是不是吉大预警期刊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e995108255, createdName=话雨临风, createdTime=Sun Apr 10 09:30:04 CST 2022, time=2022-04-10, status=1, ipAttribution=)]
    2022-10-02 ms1000000486045935

    请问通讯作者不是自己投稿后，说要通过通讯作者的邮箱确认上传，那投稿进程也只能通讯作者看到吗，这样好麻烦啊

    3

    展开3条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=915935, encodeId=e639915935e0, content=文章已经接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210513/47b3d9cb927445389014f5811b21dfd1/d6c5299aff574499b0b1989cb9ed6c93.jpg, createdBy=06772417024, createdName=1238a8f4m21(暂无昵称), createdTime=Tue Jan 12 15:52:35 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229537, encodeId=9cf6122953e16, content=偏重的研究方向：肿瘤;非编码RNA;细胞增殖<br>经验分享：6.17号投稿，第二天让补一个文件，大概18号变成with editor，24号开始就是Under Review，算是送外审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b675286815, createdName=148551b4m72(暂无昵称), createdTime=Wed Jun 29 19:42:18 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091466, encodeId=6a4d2091466ab, content=请问通讯作者不是自己投稿后，说要通过通讯作者的邮箱确认上传，那投稿进程也只能通讯作者看到吗，这样好麻烦啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7b08246697, createdName=ms1000000486045935, createdTime=Sun Oct 02 13:51:26 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216306, encodeId=5cfe1216306ca, content=ARRIVE Guidelines 在哪里下载呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIDnGE4d0tX0MqJHQj7shA3cuwKBNoG8wgelODu2fMn2rsk2aMT40SFmy9ZHQib09w7sJhDmZODwRw/132, createdBy=e43c2283843, createdName=maoweipu, createdTime=Mon May 02 13:56:31 CST 2022, time=2022-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248951, encodeId=f50c124895189, content=偏重的研究方向：细胞周期<br>经验分享：这杂志三个月了一直under review吗 有没有大牛指导下咋回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=803b6564452, createdName=ms7000001615775824, createdTime=Wed Sep 14 21:16:44 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089205, encodeId=145c208920522, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：研究类型;论文投稿;动物研究<br>经验分享：<a href='/topic/show?id=0fbb104230d8' target=_blank style='color:#2F92EE;'>#论文投稿#</a><a href='/topic/show?id=b69d5605275' target=_blank style='color:#2F92EE;'>#报告规范#</a>的要求，RCT则要求是否符合<a href='/topic/show?id=a988506424' target=_blank style='color:#2F92EE;'>#CONSORT#</a>规范（https://www.medsci.cn/guideline/show_article.do?id=71eb11c0021e2098），<a href='/topic/show?id=4c65331e364' target=_blank style='color:#2F92EE;'>#动物研究#</a>需要符合<a href='/topic/show?id=0d62104e834a' target=_blank style='color:#2F92EE;'>#ARRIVE#</a>规范，见：https://www.medsci.cn/guideline/show_article.do?id=fc3d31c002219a71 观察性研究需要符合<a href='/topic/show?id=e6b816841ea' target=_blank style='color:#2F92EE;'>#STROBE#</a>规范（https://www.medsci.cn/guideline/search?keyword=STROBE&page=1），这些在梅斯的“指南频道”中都可以检索得到的。<br>如果是动物研究，下载ARRIVE对应的文章后，文章里面有一个checklist，按checklist填写每个部分对应文章的哪一页即可，这样10分钟就能填好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104230, encryptionId=0fbb104230d8, topicName=论文投稿), TopicDto(id=56052, encryptionId=b69d5605275, topicName=报告规范), TopicDto(id=5064, encryptionId=a988506424, topicName=CONSORT), TopicDto(id=33173, encryptionId=4c65331e364, topicName=动物研究), TopicDto(id=104783, encryptionId=0d62104e834a, topicName=ARRIVE), TopicDto(id=16841, encryptionId=e6b816841ea, topicName=STROBE)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Tue Sep 20 03:46:02 CST 2022, time=2022-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212801, encodeId=8504121280160, content=偏重的研究方向：细胞凋亡;程序性坏死;细胞增殖<br>经验分享：投的纯生信， 3.22第一次投稿， 4.7日返修，给了四个月，三个审稿人， 审稿人问题不难回答，也没有让补实验， 改完以后4.13日返修回去， 4.18under review 现在等待结果中。祝好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e995108255, createdName=话雨临风, createdTime=Wed Apr 20 10:58:07 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965179, encodeId=adb69651e951, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向： 细胞周期 ; 细胞凋亡 ; 细胞增殖 <br>经验分享：优点不要钱 缺点周期很长 2020-9-4投稿 2020-9-30第一次修回 2020-11-24第二次修回 2020-12-29接收 2021-5-8 onli n e 着急毕业的审投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210513/47b3d9cb927445389014f5811b21dfd1/d6c5299aff574499b0b1989cb9ed6c93.jpg, createdBy=06772417024, createdName=1238a8f4m21(暂无昵称), createdTime=Thu May 13 12:10:37 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803989, encodeId=95c38039898a, content=请问怎么撤稿啊，急着换一个杂志，这个等太久了。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef1f5402218, createdName=ms1000000350261178, createdTime=Wed Jul 22 20:47:04 CST 2020, time=2020-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209983, encodeId=a1041209983eb, content=现在是不是吉大预警期刊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e995108255, createdName=话雨临风, createdTime=Sun Apr 10 09:30:04 CST 2022, time=2022-04-10, status=1, ipAttribution=)]
    2022-05-02 maoweipu

    ARRIVE Guidelines 在哪里下载呢？

    11

    展开11条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=915935, encodeId=e639915935e0, content=文章已经接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210513/47b3d9cb927445389014f5811b21dfd1/d6c5299aff574499b0b1989cb9ed6c93.jpg, createdBy=06772417024, createdName=1238a8f4m21(暂无昵称), createdTime=Tue Jan 12 15:52:35 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229537, encodeId=9cf6122953e16, content=偏重的研究方向：肿瘤;非编码RNA;细胞增殖<br>经验分享：6.17号投稿，第二天让补一个文件，大概18号变成with editor，24号开始就是Under Review，算是送外审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b675286815, createdName=148551b4m72(暂无昵称), createdTime=Wed Jun 29 19:42:18 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091466, encodeId=6a4d2091466ab, content=请问通讯作者不是自己投稿后，说要通过通讯作者的邮箱确认上传，那投稿进程也只能通讯作者看到吗，这样好麻烦啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7b08246697, createdName=ms1000000486045935, createdTime=Sun Oct 02 13:51:26 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216306, encodeId=5cfe1216306ca, content=ARRIVE Guidelines 在哪里下载呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIDnGE4d0tX0MqJHQj7shA3cuwKBNoG8wgelODu2fMn2rsk2aMT40SFmy9ZHQib09w7sJhDmZODwRw/132, createdBy=e43c2283843, createdName=maoweipu, createdTime=Mon May 02 13:56:31 CST 2022, time=2022-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248951, encodeId=f50c124895189, content=偏重的研究方向：细胞周期<br>经验分享：这杂志三个月了一直under review吗 有没有大牛指导下咋回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=803b6564452, createdName=ms7000001615775824, createdTime=Wed Sep 14 21:16:44 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089205, encodeId=145c208920522, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：研究类型;论文投稿;动物研究<br>经验分享：<a href='/topic/show?id=0fbb104230d8' target=_blank style='color:#2F92EE;'>#论文投稿#</a><a href='/topic/show?id=b69d5605275' target=_blank style='color:#2F92EE;'>#报告规范#</a>的要求，RCT则要求是否符合<a href='/topic/show?id=a988506424' target=_blank style='color:#2F92EE;'>#CONSORT#</a>规范（https://www.medsci.cn/guideline/show_article.do?id=71eb11c0021e2098），<a href='/topic/show?id=4c65331e364' target=_blank style='color:#2F92EE;'>#动物研究#</a>需要符合<a href='/topic/show?id=0d62104e834a' target=_blank style='color:#2F92EE;'>#ARRIVE#</a>规范，见：https://www.medsci.cn/guideline/show_article.do?id=fc3d31c002219a71 观察性研究需要符合<a href='/topic/show?id=e6b816841ea' target=_blank style='color:#2F92EE;'>#STROBE#</a>规范（https://www.medsci.cn/guideline/search?keyword=STROBE&page=1），这些在梅斯的“指南频道”中都可以检索得到的。<br>如果是动物研究，下载ARRIVE对应的文章后，文章里面有一个checklist，按checklist填写每个部分对应文章的哪一页即可，这样10分钟就能填好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104230, encryptionId=0fbb104230d8, topicName=论文投稿), TopicDto(id=56052, encryptionId=b69d5605275, topicName=报告规范), TopicDto(id=5064, encryptionId=a988506424, topicName=CONSORT), TopicDto(id=33173, encryptionId=4c65331e364, topicName=动物研究), TopicDto(id=104783, encryptionId=0d62104e834a, topicName=ARRIVE), TopicDto(id=16841, encryptionId=e6b816841ea, topicName=STROBE)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Tue Sep 20 03:46:02 CST 2022, time=2022-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212801, encodeId=8504121280160, content=偏重的研究方向：细胞凋亡;程序性坏死;细胞增殖<br>经验分享：投的纯生信， 3.22第一次投稿， 4.7日返修，给了四个月，三个审稿人， 审稿人问题不难回答，也没有让补实验， 改完以后4.13日返修回去， 4.18under review 现在等待结果中。祝好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e995108255, createdName=话雨临风, createdTime=Wed Apr 20 10:58:07 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965179, encodeId=adb69651e951, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向： 细胞周期 ; 细胞凋亡 ; 细胞增殖 <br>经验分享：优点不要钱 缺点周期很长 2020-9-4投稿 2020-9-30第一次修回 2020-11-24第二次修回 2020-12-29接收 2021-5-8 onli n e 着急毕业的审投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210513/47b3d9cb927445389014f5811b21dfd1/d6c5299aff574499b0b1989cb9ed6c93.jpg, createdBy=06772417024, createdName=1238a8f4m21(暂无昵称), createdTime=Thu May 13 12:10:37 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803989, encodeId=95c38039898a, content=请问怎么撤稿啊，急着换一个杂志，这个等太久了。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef1f5402218, createdName=ms1000000350261178, createdTime=Wed Jul 22 20:47:04 CST 2020, time=2020-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209983, encodeId=a1041209983eb, content=现在是不是吉大预警期刊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e995108255, createdName=话雨临风, createdTime=Sun Apr 10 09:30:04 CST 2022, time=2022-04-10, status=1, ipAttribution=)]
    2022-09-14 ms7000001615775824

    偏重的研究方向：细胞周期
    经验分享：这杂志三个月了一直under review吗 有没有大牛指导下咋回事

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=915935, encodeId=e639915935e0, content=文章已经接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210513/47b3d9cb927445389014f5811b21dfd1/d6c5299aff574499b0b1989cb9ed6c93.jpg, createdBy=06772417024, createdName=1238a8f4m21(暂无昵称), createdTime=Tue Jan 12 15:52:35 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229537, encodeId=9cf6122953e16, content=偏重的研究方向：肿瘤;非编码RNA;细胞增殖<br>经验分享：6.17号投稿，第二天让补一个文件，大概18号变成with editor，24号开始就是Under Review，算是送外审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b675286815, createdName=148551b4m72(暂无昵称), createdTime=Wed Jun 29 19:42:18 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091466, encodeId=6a4d2091466ab, content=请问通讯作者不是自己投稿后，说要通过通讯作者的邮箱确认上传，那投稿进程也只能通讯作者看到吗，这样好麻烦啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7b08246697, createdName=ms1000000486045935, createdTime=Sun Oct 02 13:51:26 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216306, encodeId=5cfe1216306ca, content=ARRIVE Guidelines 在哪里下载呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIDnGE4d0tX0MqJHQj7shA3cuwKBNoG8wgelODu2fMn2rsk2aMT40SFmy9ZHQib09w7sJhDmZODwRw/132, createdBy=e43c2283843, createdName=maoweipu, createdTime=Mon May 02 13:56:31 CST 2022, time=2022-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248951, encodeId=f50c124895189, content=偏重的研究方向：细胞周期<br>经验分享：这杂志三个月了一直under review吗 有没有大牛指导下咋回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=803b6564452, createdName=ms7000001615775824, createdTime=Wed Sep 14 21:16:44 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089205, encodeId=145c208920522, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：研究类型;论文投稿;动物研究<br>经验分享：<a href='/topic/show?id=0fbb104230d8' target=_blank style='color:#2F92EE;'>#论文投稿#</a><a href='/topic/show?id=b69d5605275' target=_blank style='color:#2F92EE;'>#报告规范#</a>的要求，RCT则要求是否符合<a href='/topic/show?id=a988506424' target=_blank style='color:#2F92EE;'>#CONSORT#</a>规范（https://www.medsci.cn/guideline/show_article.do?id=71eb11c0021e2098），<a href='/topic/show?id=4c65331e364' target=_blank style='color:#2F92EE;'>#动物研究#</a>需要符合<a href='/topic/show?id=0d62104e834a' target=_blank style='color:#2F92EE;'>#ARRIVE#</a>规范，见：https://www.medsci.cn/guideline/show_article.do?id=fc3d31c002219a71 观察性研究需要符合<a href='/topic/show?id=e6b816841ea' target=_blank style='color:#2F92EE;'>#STROBE#</a>规范（https://www.medsci.cn/guideline/search?keyword=STROBE&page=1），这些在梅斯的“指南频道”中都可以检索得到的。<br>如果是动物研究，下载ARRIVE对应的文章后，文章里面有一个checklist，按checklist填写每个部分对应文章的哪一页即可，这样10分钟就能填好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104230, encryptionId=0fbb104230d8, topicName=论文投稿), TopicDto(id=56052, encryptionId=b69d5605275, topicName=报告规范), TopicDto(id=5064, encryptionId=a988506424, topicName=CONSORT), TopicDto(id=33173, encryptionId=4c65331e364, topicName=动物研究), TopicDto(id=104783, encryptionId=0d62104e834a, topicName=ARRIVE), TopicDto(id=16841, encryptionId=e6b816841ea, topicName=STROBE)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Tue Sep 20 03:46:02 CST 2022, time=2022-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212801, encodeId=8504121280160, content=偏重的研究方向：细胞凋亡;程序性坏死;细胞增殖<br>经验分享：投的纯生信， 3.22第一次投稿， 4.7日返修，给了四个月，三个审稿人， 审稿人问题不难回答，也没有让补实验， 改完以后4.13日返修回去， 4.18under review 现在等待结果中。祝好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e995108255, createdName=话雨临风, createdTime=Wed Apr 20 10:58:07 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965179, encodeId=adb69651e951, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向： 细胞周期 ; 细胞凋亡 ; 细胞增殖 <br>经验分享：优点不要钱 缺点周期很长 2020-9-4投稿 2020-9-30第一次修回 2020-11-24第二次修回 2020-12-29接收 2021-5-8 onli n e 着急毕业的审投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210513/47b3d9cb927445389014f5811b21dfd1/d6c5299aff574499b0b1989cb9ed6c93.jpg, createdBy=06772417024, createdName=1238a8f4m21(暂无昵称), createdTime=Thu May 13 12:10:37 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803989, encodeId=95c38039898a, content=请问怎么撤稿啊，急着换一个杂志，这个等太久了。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef1f5402218, createdName=ms1000000350261178, createdTime=Wed Jul 22 20:47:04 CST 2020, time=2020-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209983, encodeId=a1041209983eb, content=现在是不是吉大预警期刊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e995108255, createdName=话雨临风, createdTime=Sun Apr 10 09:30:04 CST 2022, time=2022-04-10, status=1, ipAttribution=)]
    2022-09-20 小小医者

    审稿速度:3.0 | 投稿命中率:75.0
    偏重的研究方向：研究类型;论文投稿;动物研究
    经验分享：#论文投稿##报告规范#的要求，RCT则要求是否符合#CONSORT#规范（https://www.medsci.cn/guideline/show_article.do?id=71eb11c0021e2098），#动物研究#需要符合#ARRIVE#规范，见：https://www.medsci.cn/guideline/show_article.do?id=fc3d31c002219a71 观察性研究需要符合#STROBE#规范（https://www.medsci.cn/guideline/search?keyword=STROBE&page=1），这些在梅斯的“指南频道”中都可以检索得到的。
    如果是动物研究，下载ARRIVE对应的文章后，文章里面有一个checklist，按checklist填写每个部分对应文章的哪一页即可，这样10分钟就能填好。

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=915935, encodeId=e639915935e0, content=文章已经接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210513/47b3d9cb927445389014f5811b21dfd1/d6c5299aff574499b0b1989cb9ed6c93.jpg, createdBy=06772417024, createdName=1238a8f4m21(暂无昵称), createdTime=Tue Jan 12 15:52:35 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229537, encodeId=9cf6122953e16, content=偏重的研究方向：肿瘤;非编码RNA;细胞增殖<br>经验分享：6.17号投稿，第二天让补一个文件，大概18号变成with editor，24号开始就是Under Review，算是送外审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b675286815, createdName=148551b4m72(暂无昵称), createdTime=Wed Jun 29 19:42:18 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091466, encodeId=6a4d2091466ab, content=请问通讯作者不是自己投稿后，说要通过通讯作者的邮箱确认上传，那投稿进程也只能通讯作者看到吗，这样好麻烦啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7b08246697, createdName=ms1000000486045935, createdTime=Sun Oct 02 13:51:26 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216306, encodeId=5cfe1216306ca, content=ARRIVE Guidelines 在哪里下载呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIDnGE4d0tX0MqJHQj7shA3cuwKBNoG8wgelODu2fMn2rsk2aMT40SFmy9ZHQib09w7sJhDmZODwRw/132, createdBy=e43c2283843, createdName=maoweipu, createdTime=Mon May 02 13:56:31 CST 2022, time=2022-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248951, encodeId=f50c124895189, content=偏重的研究方向：细胞周期<br>经验分享：这杂志三个月了一直under review吗 有没有大牛指导下咋回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=803b6564452, createdName=ms7000001615775824, createdTime=Wed Sep 14 21:16:44 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089205, encodeId=145c208920522, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：研究类型;论文投稿;动物研究<br>经验分享：<a href='/topic/show?id=0fbb104230d8' target=_blank style='color:#2F92EE;'>#论文投稿#</a><a href='/topic/show?id=b69d5605275' target=_blank style='color:#2F92EE;'>#报告规范#</a>的要求，RCT则要求是否符合<a href='/topic/show?id=a988506424' target=_blank style='color:#2F92EE;'>#CONSORT#</a>规范（https://www.medsci.cn/guideline/show_article.do?id=71eb11c0021e2098），<a href='/topic/show?id=4c65331e364' target=_blank style='color:#2F92EE;'>#动物研究#</a>需要符合<a href='/topic/show?id=0d62104e834a' target=_blank style='color:#2F92EE;'>#ARRIVE#</a>规范，见：https://www.medsci.cn/guideline/show_article.do?id=fc3d31c002219a71 观察性研究需要符合<a href='/topic/show?id=e6b816841ea' target=_blank style='color:#2F92EE;'>#STROBE#</a>规范（https://www.medsci.cn/guideline/search?keyword=STROBE&page=1），这些在梅斯的“指南频道”中都可以检索得到的。<br>如果是动物研究，下载ARRIVE对应的文章后，文章里面有一个checklist，按checklist填写每个部分对应文章的哪一页即可，这样10分钟就能填好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104230, encryptionId=0fbb104230d8, topicName=论文投稿), TopicDto(id=56052, encryptionId=b69d5605275, topicName=报告规范), TopicDto(id=5064, encryptionId=a988506424, topicName=CONSORT), TopicDto(id=33173, encryptionId=4c65331e364, topicName=动物研究), TopicDto(id=104783, encryptionId=0d62104e834a, topicName=ARRIVE), TopicDto(id=16841, encryptionId=e6b816841ea, topicName=STROBE)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Tue Sep 20 03:46:02 CST 2022, time=2022-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212801, encodeId=8504121280160, content=偏重的研究方向：细胞凋亡;程序性坏死;细胞增殖<br>经验分享：投的纯生信， 3.22第一次投稿， 4.7日返修，给了四个月，三个审稿人， 审稿人问题不难回答，也没有让补实验， 改完以后4.13日返修回去， 4.18under review 现在等待结果中。祝好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e995108255, createdName=话雨临风, createdTime=Wed Apr 20 10:58:07 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965179, encodeId=adb69651e951, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向： 细胞周期 ; 细胞凋亡 ; 细胞增殖 <br>经验分享：优点不要钱 缺点周期很长 2020-9-4投稿 2020-9-30第一次修回 2020-11-24第二次修回 2020-12-29接收 2021-5-8 onli n e 着急毕业的审投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210513/47b3d9cb927445389014f5811b21dfd1/d6c5299aff574499b0b1989cb9ed6c93.jpg, createdBy=06772417024, createdName=1238a8f4m21(暂无昵称), createdTime=Thu May 13 12:10:37 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803989, encodeId=95c38039898a, content=请问怎么撤稿啊，急着换一个杂志，这个等太久了。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef1f5402218, createdName=ms1000000350261178, createdTime=Wed Jul 22 20:47:04 CST 2020, time=2020-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209983, encodeId=a1041209983eb, content=现在是不是吉大预警期刊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e995108255, createdName=话雨临风, createdTime=Sun Apr 10 09:30:04 CST 2022, time=2022-04-10, status=1, ipAttribution=)]
    2022-04-20 话雨临风

    偏重的研究方向：细胞凋亡;程序性坏死;细胞增殖
    经验分享：投的纯生信， 3.22第一次投稿， 4.7日返修，给了四个月，三个审稿人， 审稿人问题不难回答，也没有让补实验， 改完以后4.13日返修回去， 4.18under review 现在等待结果中。祝好

    4

    展开4条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=915935, encodeId=e639915935e0, content=文章已经接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210513/47b3d9cb927445389014f5811b21dfd1/d6c5299aff574499b0b1989cb9ed6c93.jpg, createdBy=06772417024, createdName=1238a8f4m21(暂无昵称), createdTime=Tue Jan 12 15:52:35 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229537, encodeId=9cf6122953e16, content=偏重的研究方向：肿瘤;非编码RNA;细胞增殖<br>经验分享：6.17号投稿，第二天让补一个文件，大概18号变成with editor，24号开始就是Under Review，算是送外审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b675286815, createdName=148551b4m72(暂无昵称), createdTime=Wed Jun 29 19:42:18 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091466, encodeId=6a4d2091466ab, content=请问通讯作者不是自己投稿后，说要通过通讯作者的邮箱确认上传，那投稿进程也只能通讯作者看到吗，这样好麻烦啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7b08246697, createdName=ms1000000486045935, createdTime=Sun Oct 02 13:51:26 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216306, encodeId=5cfe1216306ca, content=ARRIVE Guidelines 在哪里下载呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIDnGE4d0tX0MqJHQj7shA3cuwKBNoG8wgelODu2fMn2rsk2aMT40SFmy9ZHQib09w7sJhDmZODwRw/132, createdBy=e43c2283843, createdName=maoweipu, createdTime=Mon May 02 13:56:31 CST 2022, time=2022-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248951, encodeId=f50c124895189, content=偏重的研究方向：细胞周期<br>经验分享：这杂志三个月了一直under review吗 有没有大牛指导下咋回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=803b6564452, createdName=ms7000001615775824, createdTime=Wed Sep 14 21:16:44 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089205, encodeId=145c208920522, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：研究类型;论文投稿;动物研究<br>经验分享：<a href='/topic/show?id=0fbb104230d8' target=_blank style='color:#2F92EE;'>#论文投稿#</a><a href='/topic/show?id=b69d5605275' target=_blank style='color:#2F92EE;'>#报告规范#</a>的要求，RCT则要求是否符合<a href='/topic/show?id=a988506424' target=_blank style='color:#2F92EE;'>#CONSORT#</a>规范（https://www.medsci.cn/guideline/show_article.do?id=71eb11c0021e2098），<a href='/topic/show?id=4c65331e364' target=_blank style='color:#2F92EE;'>#动物研究#</a>需要符合<a href='/topic/show?id=0d62104e834a' target=_blank style='color:#2F92EE;'>#ARRIVE#</a>规范，见：https://www.medsci.cn/guideline/show_article.do?id=fc3d31c002219a71 观察性研究需要符合<a href='/topic/show?id=e6b816841ea' target=_blank style='color:#2F92EE;'>#STROBE#</a>规范（https://www.medsci.cn/guideline/search?keyword=STROBE&page=1），这些在梅斯的“指南频道”中都可以检索得到的。<br>如果是动物研究，下载ARRIVE对应的文章后，文章里面有一个checklist，按checklist填写每个部分对应文章的哪一页即可，这样10分钟就能填好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104230, encryptionId=0fbb104230d8, topicName=论文投稿), TopicDto(id=56052, encryptionId=b69d5605275, topicName=报告规范), TopicDto(id=5064, encryptionId=a988506424, topicName=CONSORT), TopicDto(id=33173, encryptionId=4c65331e364, topicName=动物研究), TopicDto(id=104783, encryptionId=0d62104e834a, topicName=ARRIVE), TopicDto(id=16841, encryptionId=e6b816841ea, topicName=STROBE)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Tue Sep 20 03:46:02 CST 2022, time=2022-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212801, encodeId=8504121280160, content=偏重的研究方向：细胞凋亡;程序性坏死;细胞增殖<br>经验分享：投的纯生信， 3.22第一次投稿， 4.7日返修，给了四个月，三个审稿人， 审稿人问题不难回答，也没有让补实验， 改完以后4.13日返修回去， 4.18under review 现在等待结果中。祝好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e995108255, createdName=话雨临风, createdTime=Wed Apr 20 10:58:07 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965179, encodeId=adb69651e951, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向： 细胞周期 ; 细胞凋亡 ; 细胞增殖 <br>经验分享：优点不要钱 缺点周期很长 2020-9-4投稿 2020-9-30第一次修回 2020-11-24第二次修回 2020-12-29接收 2021-5-8 onli n e 着急毕业的审投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210513/47b3d9cb927445389014f5811b21dfd1/d6c5299aff574499b0b1989cb9ed6c93.jpg, createdBy=06772417024, createdName=1238a8f4m21(暂无昵称), createdTime=Thu May 13 12:10:37 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803989, encodeId=95c38039898a, content=请问怎么撤稿啊，急着换一个杂志，这个等太久了。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef1f5402218, createdName=ms1000000350261178, createdTime=Wed Jul 22 20:47:04 CST 2020, time=2020-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209983, encodeId=a1041209983eb, content=现在是不是吉大预警期刊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e995108255, createdName=话雨临风, createdTime=Sun Apr 10 09:30:04 CST 2022, time=2022-04-10, status=1, ipAttribution=)]
    2021-05-13 1238a8f4m21(暂无昵称)

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向： 细胞周期 ; 细胞凋亡 ; 细胞增殖
    经验分享：优点不要钱 缺点周期很长 2020-9-4投稿 2020-9-30第一次修回 2020-11-24第二次修回 2020-12-29接收 2021-5-8 onli n e 着急毕业的审投

    9

    展开9条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=915935, encodeId=e639915935e0, content=文章已经接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210513/47b3d9cb927445389014f5811b21dfd1/d6c5299aff574499b0b1989cb9ed6c93.jpg, createdBy=06772417024, createdName=1238a8f4m21(暂无昵称), createdTime=Tue Jan 12 15:52:35 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229537, encodeId=9cf6122953e16, content=偏重的研究方向：肿瘤;非编码RNA;细胞增殖<br>经验分享：6.17号投稿，第二天让补一个文件，大概18号变成with editor，24号开始就是Under Review，算是送外审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b675286815, createdName=148551b4m72(暂无昵称), createdTime=Wed Jun 29 19:42:18 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091466, encodeId=6a4d2091466ab, content=请问通讯作者不是自己投稿后，说要通过通讯作者的邮箱确认上传，那投稿进程也只能通讯作者看到吗，这样好麻烦啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7b08246697, createdName=ms1000000486045935, createdTime=Sun Oct 02 13:51:26 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216306, encodeId=5cfe1216306ca, content=ARRIVE Guidelines 在哪里下载呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIDnGE4d0tX0MqJHQj7shA3cuwKBNoG8wgelODu2fMn2rsk2aMT40SFmy9ZHQib09w7sJhDmZODwRw/132, createdBy=e43c2283843, createdName=maoweipu, createdTime=Mon May 02 13:56:31 CST 2022, time=2022-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248951, encodeId=f50c124895189, content=偏重的研究方向：细胞周期<br>经验分享：这杂志三个月了一直under review吗 有没有大牛指导下咋回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=803b6564452, createdName=ms7000001615775824, createdTime=Wed Sep 14 21:16:44 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089205, encodeId=145c208920522, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：研究类型;论文投稿;动物研究<br>经验分享：<a href='/topic/show?id=0fbb104230d8' target=_blank style='color:#2F92EE;'>#论文投稿#</a><a href='/topic/show?id=b69d5605275' target=_blank style='color:#2F92EE;'>#报告规范#</a>的要求，RCT则要求是否符合<a href='/topic/show?id=a988506424' target=_blank style='color:#2F92EE;'>#CONSORT#</a>规范（https://www.medsci.cn/guideline/show_article.do?id=71eb11c0021e2098），<a href='/topic/show?id=4c65331e364' target=_blank style='color:#2F92EE;'>#动物研究#</a>需要符合<a href='/topic/show?id=0d62104e834a' target=_blank style='color:#2F92EE;'>#ARRIVE#</a>规范，见：https://www.medsci.cn/guideline/show_article.do?id=fc3d31c002219a71 观察性研究需要符合<a href='/topic/show?id=e6b816841ea' target=_blank style='color:#2F92EE;'>#STROBE#</a>规范（https://www.medsci.cn/guideline/search?keyword=STROBE&page=1），这些在梅斯的“指南频道”中都可以检索得到的。<br>如果是动物研究，下载ARRIVE对应的文章后，文章里面有一个checklist，按checklist填写每个部分对应文章的哪一页即可，这样10分钟就能填好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104230, encryptionId=0fbb104230d8, topicName=论文投稿), TopicDto(id=56052, encryptionId=b69d5605275, topicName=报告规范), TopicDto(id=5064, encryptionId=a988506424, topicName=CONSORT), TopicDto(id=33173, encryptionId=4c65331e364, topicName=动物研究), TopicDto(id=104783, encryptionId=0d62104e834a, topicName=ARRIVE), TopicDto(id=16841, encryptionId=e6b816841ea, topicName=STROBE)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Tue Sep 20 03:46:02 CST 2022, time=2022-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212801, encodeId=8504121280160, content=偏重的研究方向：细胞凋亡;程序性坏死;细胞增殖<br>经验分享：投的纯生信， 3.22第一次投稿， 4.7日返修，给了四个月，三个审稿人， 审稿人问题不难回答，也没有让补实验， 改完以后4.13日返修回去， 4.18under review 现在等待结果中。祝好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e995108255, createdName=话雨临风, createdTime=Wed Apr 20 10:58:07 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965179, encodeId=adb69651e951, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向： 细胞周期 ; 细胞凋亡 ; 细胞增殖 <br>经验分享：优点不要钱 缺点周期很长 2020-9-4投稿 2020-9-30第一次修回 2020-11-24第二次修回 2020-12-29接收 2021-5-8 onli n e 着急毕业的审投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210513/47b3d9cb927445389014f5811b21dfd1/d6c5299aff574499b0b1989cb9ed6c93.jpg, createdBy=06772417024, createdName=1238a8f4m21(暂无昵称), createdTime=Thu May 13 12:10:37 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803989, encodeId=95c38039898a, content=请问怎么撤稿啊，急着换一个杂志，这个等太久了。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef1f5402218, createdName=ms1000000350261178, createdTime=Wed Jul 22 20:47:04 CST 2020, time=2020-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209983, encodeId=a1041209983eb, content=现在是不是吉大预警期刊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e995108255, createdName=话雨临风, createdTime=Sun Apr 10 09:30:04 CST 2022, time=2022-04-10, status=1, ipAttribution=)]
    2020-07-22 ms1000000350261178

    请问怎么撤稿啊，急着换一个杂志，这个等太久了。。

    4

    展开4条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=915935, encodeId=e639915935e0, content=文章已经接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210513/47b3d9cb927445389014f5811b21dfd1/d6c5299aff574499b0b1989cb9ed6c93.jpg, createdBy=06772417024, createdName=1238a8f4m21(暂无昵称), createdTime=Tue Jan 12 15:52:35 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229537, encodeId=9cf6122953e16, content=偏重的研究方向：肿瘤;非编码RNA;细胞增殖<br>经验分享：6.17号投稿，第二天让补一个文件，大概18号变成with editor，24号开始就是Under Review，算是送外审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b675286815, createdName=148551b4m72(暂无昵称), createdTime=Wed Jun 29 19:42:18 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091466, encodeId=6a4d2091466ab, content=请问通讯作者不是自己投稿后，说要通过通讯作者的邮箱确认上传，那投稿进程也只能通讯作者看到吗，这样好麻烦啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7b08246697, createdName=ms1000000486045935, createdTime=Sun Oct 02 13:51:26 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216306, encodeId=5cfe1216306ca, content=ARRIVE Guidelines 在哪里下载呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIDnGE4d0tX0MqJHQj7shA3cuwKBNoG8wgelODu2fMn2rsk2aMT40SFmy9ZHQib09w7sJhDmZODwRw/132, createdBy=e43c2283843, createdName=maoweipu, createdTime=Mon May 02 13:56:31 CST 2022, time=2022-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248951, encodeId=f50c124895189, content=偏重的研究方向：细胞周期<br>经验分享：这杂志三个月了一直under review吗 有没有大牛指导下咋回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=803b6564452, createdName=ms7000001615775824, createdTime=Wed Sep 14 21:16:44 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089205, encodeId=145c208920522, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：研究类型;论文投稿;动物研究<br>经验分享：<a href='/topic/show?id=0fbb104230d8' target=_blank style='color:#2F92EE;'>#论文投稿#</a><a href='/topic/show?id=b69d5605275' target=_blank style='color:#2F92EE;'>#报告规范#</a>的要求，RCT则要求是否符合<a href='/topic/show?id=a988506424' target=_blank style='color:#2F92EE;'>#CONSORT#</a>规范（https://www.medsci.cn/guideline/show_article.do?id=71eb11c0021e2098），<a href='/topic/show?id=4c65331e364' target=_blank style='color:#2F92EE;'>#动物研究#</a>需要符合<a href='/topic/show?id=0d62104e834a' target=_blank style='color:#2F92EE;'>#ARRIVE#</a>规范，见：https://www.medsci.cn/guideline/show_article.do?id=fc3d31c002219a71 观察性研究需要符合<a href='/topic/show?id=e6b816841ea' target=_blank style='color:#2F92EE;'>#STROBE#</a>规范（https://www.medsci.cn/guideline/search?keyword=STROBE&page=1），这些在梅斯的“指南频道”中都可以检索得到的。<br>如果是动物研究，下载ARRIVE对应的文章后，文章里面有一个checklist，按checklist填写每个部分对应文章的哪一页即可，这样10分钟就能填好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104230, encryptionId=0fbb104230d8, topicName=论文投稿), TopicDto(id=56052, encryptionId=b69d5605275, topicName=报告规范), TopicDto(id=5064, encryptionId=a988506424, topicName=CONSORT), TopicDto(id=33173, encryptionId=4c65331e364, topicName=动物研究), TopicDto(id=104783, encryptionId=0d62104e834a, topicName=ARRIVE), TopicDto(id=16841, encryptionId=e6b816841ea, topicName=STROBE)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Tue Sep 20 03:46:02 CST 2022, time=2022-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212801, encodeId=8504121280160, content=偏重的研究方向：细胞凋亡;程序性坏死;细胞增殖<br>经验分享：投的纯生信， 3.22第一次投稿， 4.7日返修，给了四个月，三个审稿人， 审稿人问题不难回答，也没有让补实验， 改完以后4.13日返修回去， 4.18under review 现在等待结果中。祝好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e995108255, createdName=话雨临风, createdTime=Wed Apr 20 10:58:07 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965179, encodeId=adb69651e951, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向： 细胞周期 ; 细胞凋亡 ; 细胞增殖 <br>经验分享：优点不要钱 缺点周期很长 2020-9-4投稿 2020-9-30第一次修回 2020-11-24第二次修回 2020-12-29接收 2021-5-8 onli n e 着急毕业的审投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210513/47b3d9cb927445389014f5811b21dfd1/d6c5299aff574499b0b1989cb9ed6c93.jpg, createdBy=06772417024, createdName=1238a8f4m21(暂无昵称), createdTime=Thu May 13 12:10:37 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803989, encodeId=95c38039898a, content=请问怎么撤稿啊，急着换一个杂志，这个等太久了。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef1f5402218, createdName=ms1000000350261178, createdTime=Wed Jul 22 20:47:04 CST 2020, time=2020-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209983, encodeId=a1041209983eb, content=现在是不是吉大预警期刊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e995108255, createdName=话雨临风, createdTime=Sun Apr 10 09:30:04 CST 2022, time=2022-04-10, status=1, ipAttribution=)]
    2022-04-10 话雨临风

    现在是不是吉大预警期刊啊

    0

共290条页码: 2/29页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分